Skip to main
KMB

Kimberly-Clark (KMB) Stock Forecast & Price Target

Kimberly-Clark (KMB) Analyst Ratings

Based on 12 analyst ratings
Hold
Strong Buy 8%
Buy 17%
Hold 67%
Sell 0%
Strong Sell 8%

Bulls say

Kimberly-Clark is a prominent player in the tissue and hygiene market, with over half of its sales derived from personal care products and an additional third from consumer tissue offerings. The company is poised for growth with an anticipated robust innovation pipeline in 2026, supported by advancements in technology that could enhance product offerings and market reach. Furthermore, the strategic addition of Kenvue's consumer health portfolio anticipated in the latter half of 2026 is likely to bolster Kimberly-Clark's overall revenue base and market presence, particularly in a competitive environment.

Bears say

Kimberly-Clark is experiencing a significant negative shift in its sales outlook, with a projected organic sales decline of -4.0% in North America for the third quarter of 2025, a stark contrast to the prior estimate of +4.5%. Additionally, the company reported a -2.7% decline in U.S. measured retail sales during the same timeframe, indicating persistent struggles in maintaining market performance. Earnings per share (EPS) estimates have been revised downward, with forecasts for fiscal year 2025 decreased from $7.60 to $7.41 and for 2026 from $8.00 to $7.85, which reflects ongoing challenges in profitability and revenue generation.

Kimberly-Clark (KMB) has been analyzed by 12 analysts, with a consensus rating of Hold. 8% of analysts recommend a Strong Buy, 17% recommend Buy, 67% suggest Holding, 0% advise Selling, and 8% predict a Strong Sell.

This aggregate rating is based on analysts' research of Kimberly-Clark and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Kimberly-Clark (KMB) Forecast

Analysts have given Kimberly-Clark (KMB) a Hold based on their latest research and market trends.

According to 12 analysts, Kimberly-Clark (KMB) has a Hold consensus rating as of Jan 6, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $123.83, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $123.83, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Kimberly-Clark (KMB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.